- This event has passed.
HALO 2022 Q3
August 9, 2022
Halozyme Therapeutics (HALO) reports qtrly profits (EPS):
- Reported: $0.53 vs. $0.62 = -15%
- Estimates: $0.50 vs. $0.62 = -19%
- Beat the street by $0.03
- Revenue: +12%
Halozyme Therapeutics (HALO) reports qtrly profits (EPS):
